- Home
- OSRH vs IBIO Comparison
OSRH vs IBIO Comparison
Compare OSRH & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- IBIO
- Stock Information
- Founded
- OSRH N/A
- IBIO 2008
- Country
- OSRH United States
- IBIO United States
- Employees
- OSRH N/A
- IBIO N/A
- Industry
- OSRH
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- OSRH
- IBIO Health Care
- Exchange
- OSRH Nasdaq
- IBIO Nasdaq
- Market Cap
- OSRH 19.0M
- IBIO 15.9M
- IPO Year
- OSRH N/A
- IBIO N/A
- Fundamental
- Price
- OSRH $0.98
- IBIO $0.73
- Analyst Decision
- OSRH
- IBIO Strong Buy
- Analyst Count
- OSRH 0
- IBIO 2
- Target Price
- OSRH N/A
- IBIO $5.50
- AVG Volume (30 Days)
- OSRH 927.3K
- IBIO 729.8K
- Earning Date
- OSRH 08-24-2025
- IBIO 09-19-2025
- Dividend Yield
- OSRH N/A
- IBIO N/A
- EPS Growth
- OSRH N/A
- IBIO N/A
- EPS
- OSRH N/A
- IBIO N/A
- Revenue
- OSRH N/A
- IBIO $375,000.00
- Revenue This Year
- OSRH N/A
- IBIO $36.00
- Revenue Next Year
- OSRH N/A
- IBIO N/A
- P/E Ratio
- OSRH N/A
- IBIO N/A
- Revenue Growth
- OSRH N/A
- IBIO 650.00
- 52 Week Low
- OSRH $0.90
- IBIO $0.64
- 52 Week High
- OSRH $13.40
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- OSRH N/A
- IBIO 41.88
- Support Level
- OSRH N/A
- IBIO $0.71
- Resistance Level
- OSRH N/A
- IBIO $0.78
- Average True Range (ATR)
- OSRH 0.00
- IBIO 0.04
- MACD
- OSRH 0.00
- IBIO 0.01
- Stochastic Oscillator
- OSRH 0.00
- IBIO 8.73
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.